Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Lung Cancer. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

featured
Published in Lung Cancer

Expert Opinion / Cases · November 09, 2022

Resected Non-Small Cell Lung Cancer: How Far to Go With Molecular Testing?

Written by
Michael J. Grant MD

 

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Lewis Attas

    Nov 11, 2022

    By current NCCN guidelines  3 is the answer.  I wonder who is doing full NGS

  • Oct 06, 2024

    Pending Moderator approval.
    Delete

Further Reading